Search results
Liver biopsy may also uncover another concomitant liver disease, which can occur in 40% of patients with HS. 7 Classic liver biopsy findings for HS show noncaseating granulomas with macrophages in the center surrounded by a rim of other inflammatory cells (Fig. 4). 7 When compared with PBC and PSC, these granulomas are scattered throughout the ...
Hepatic involvement is seen in almost 50% of cases of sarcoidosis, though the clinical consequences are variable. In this study, we describe the case of three patients from our institution with hepatic sarcoidosis. Two of them eventually went on to develop liver cirrhosis. Keywords: epithelioid granuloma, hepatic sarcoidosis, sarcoidosis, case ...
20 sty 2024 · Hepatic sarcoidosis presents with distinct clinicopathologic characteristics that differentiate it from other types of granulomatous liver disease. Although hepatic sarcoidosis is most commonly asymptomatic, it can result in progressive liver disease with various associated complications.
30 sty 2019 · Sarcoidosis can also affect calcium metabolism, the nervous system, the liver and spleen, muscles, bones and joints, the kidneys, lymph nodes, or any other organ. When to see a doctor. See your doctor if you have signs and symptoms of sarcoidosis.
1 gru 2021 · To confirm the diagnosis of hepatic sarcoidosis, we collected data on hepatic lesions detected in imaging studies, characteristics of hepatic granulomas in biopsies, clinical and/or laboratory evidence of liver involvement, and extrahepatic manifestations of systemic sarcoidosis.
10 kwi 2020 · Sarcoidosis is a multisystem granulomatous disease with nonspecific clinical manifestations that commonly affects the pulmonary system and other organs including the eyes, skin, liver, spleen, and lymph nodes.
Some manifestations of sarcoidosis are not organ-specific and probably are the result of a release of mediators from the sarcoid granuloma. Two such manifestations include small fiber neuropathy and fatigue syndromes, and they are observed in a large percentage of patients.
